Strive, Inc. · NASDAQ:ASST
Strive — Asset Entities — Merger or Acquisition (May 2025)
9 slides from Strive's merger presentation, May 27, 2025
Slide 1: Strive Asset Management
STRIV= ASSET MANAGEMENT May 2025
Slide 2: Cautionary Statement Regarding Forward-Looking Statements
2 Cautionary Statement Regarding Forward - Looking Statements Certain statements herein and the documents incorporated herein by reference may constitute “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 19
Slide 3: Strive Executing Ahead of Schedule From Merger Announcement with Asset Entities
3 STRIVE ASSET MANAGEMENT IS ALREADY EXECUTING AHEAD OF SCHEDULE FROM MERGER ANNOUNCEMENT WITH ASSET ENTITIES (NASDAQ: ASST) ON MAY 7, 2025 TRANSACTION DETAILS • STRIVE ASSET MANAGEMENT AND ASSET ENTITIES (NASDAQ: ASST) ANNOUNCED $750M PRIVATE INVESTMENT TO FUND FIRST WAVE OF BITCOIN ACCUMULATION •
Slide 4: Strive Stands Alone in Seeking Bitcoin Alpha Generation
STRIVE STANDS ALONE IN SEEKING BITCOIN ALPHA GENERATION 4 BETA - GENERATING BITCOIN TREASURY STRATEGIES INCLUDE: STRIVE IS LEVERAGING PROPRIETARY IN - HOUSE EXPERTISE TO EXECUTE ON ALPHA STRATEGIES: STRIVE IS POISED TO BECOME THE 1 ST MULTI - STRATEGY ALPHA - GENERATING BITCOIN TREASURY COMPANY Fram
Slide 5: How Should Investors in a Bitcoin Treasury Company Value Alpha Generation?
HOW SHOULD INVESTORS IN A BITCOIN TREASURY COMPANY VALUE ALPHA GENERATION? 5 Annual Alpha 5% 4% 3% 2% 1% 0% Bitcoin ARR% 2.1x 1.8x 1.6x 1.3x 1.2x 1.0x 0% 3.4x 2.8x 2.2x 1.7x 1.3x 1.0x 10% 6.5x 5.0x 3.8x 2.7x 1.8x 1.0x 20% 13.7x 10.4x 7.5x 5.0x 2.8x 1.0x 30% 30.1x 22.5x 15.8x 10.1x 5.2x 1.0x 40% 66.0
Slide 6: Our Plan to Acquire Cash for a Discount in the Biotech Industry
Preliminary discussions with potential initial target already underway. 6 OUR PLAN TO ACQUIRE CASH FOR A DISCOUNT IN THE BIOTECH INDUSTRY The Strive Strategy 1. EXCHANGE SHARES FOR STRIVE EQUITY Unlike a hedge fund, we can merge the biotech company into Strive and offer shareholders liquid equity. 2
Slide 7: The Biotech 'Trapped Cash' Landscape: $30BN+ Opportunity
THE BIOTECH ‘TRAPPED CASH’ LANDSCAPE: $30BN+ OPPORTUNITY 7 1 – Jefferies Research , Factset 2 - S&P Capital IQ. Predominantly includes Biopharma and Pharmaceuticals (~90%). Also includes Healthcare Technology, Medical E qui pment and Life Sciences Tools and Servicing. 3 – Alis Biosciences Launches F
Slide 8: Strategic Opportunity: Distressed Bitcoin Litigation Claims
STRATEGIC OPPORTUNITY: DISTRESSED BITCOIN LITIGATION CLAIMS 8 Market Price for Definitive Legal Claims on Bitcoin with ~2 Year Duration Risk: 20% - 30% Discount EXPERTISE Bankruptcy Claims Estate Property DIPs and Distressed Lending Strive can generate value by purchasing Bitcoin claims with definit
Slide 9: Equity Tranches of Structured Bitcoin Can Offer Attractive Returns
EQUITY TRANCHES OF STRUCTURED BITCOIN CAN OFFER ATTRACTIVE RETURNS If Bitcoin remains, next bond is paid Remaining Bitcoin goes to equity At maturity, Bitcoin is used to repay debt and equity Funds are raised to buy Bitcoin Bitcoin is held as collateral EQUITY JUNIOR DEBT SENIOR DEBT Senior debt is